Bone marrow-derived endothelial progenitor cells (EPCs) are present in the systemic
circulation, are augmented in response to certain cytokines and/or tissue ischemia, and are …

Endothelial progenitor cells (EPCs) play a role in endogenous neovascularization of
ischaemic tissues. Isolation and characterization of EPCs from circulating mononuclear cells …

Cardiovascular diseases (CVDs) are the leading cause of death in both developed and
developing countries. Endothelial progenitor cells (EPCs) are derived from hematopoietic …

Since their identification in 1997, bone marrow derived endothelial progenitor cells (EPCs)
have been studied for their role in the endogenous maintenance and repair of endothelium …

Background Stem cells/progenitors are central to the development of cell therapy
approaches for vascular ischemic diseases. The crucial step in rescuing tissues from …

The basis for native as well as therapeutic neovascularization is not restricted to
angiogenesis but includes postnatal vasculogenesis. Our laboratory and others' have …

Endothelial dysfunction is a hallmark of cardiovascular and cerebrovascular disease.
Restoring the endothelial lining to normal is critical for slowing or reversing the progression …

Endothelial progenitor cells (EPCs) were shown to be present in systemic circulation and
cord blood. We investigated whether EPCs display specific properties compared with mature …

Background Transplantation of endothelial progenitor cells (EPCs)/endothelial cells (ECs)
has been used for the treatment of ischemic diseases and hemophilia A, due to their great …

Endothelial progenitor cells (EPCs) are peripheral blood mononuclear cells that can
differentiate into mature endothelial cells. Adult EPCs were first discovered in human …